Projects
![]()
No projects found
Investors
New
DAO Treasuries
DATs
Lend / Borrow APRs
Chains
Categories
Spaces
DeSci Office Hours
Recorded: Sept. 15, 2025 Duration: 1:01:48Space Recording
Short Summary
Exciting developments in decentralized science (DSci) are underway, with multiple project launches and innovative partnerships aimed at enhancing health awareness and community engagement. The upcoming Poop Monsters app and Raptor's token transition highlight the dynamic nature of the crypto ecosystem.
Full Transcription
oh hello hey carlin gmgm can you hear me yeah can you hear me? Yes, perfect.
Nice. How's it going, brov?
Going good.
A lot of different moving parts.
No, for sure.
For sure.
Bunch of launches scheduled.
And yeah,
DCI is set up, you know,
boiling with launches here and there.
Yeah. It's hard to keep launches here and there. Yeah.
It's hard to keep track on, man.
Definitely.
There's a lot coming up.
So, I mean, let's just get right into it.
I'm Carlin.
I'm calling in from Chicago today.
It's 10 a.m. Central Standard Time.
The weather is nice outside, but'm stuck in lab uh working on some
experiments for my reviews for my paper
awesome yeah hey hi guys i'm kiho uh i'm carlin's co-host um i'm reporting from india It's half past 8 p.m. A little warmer today.
But, yeah, the weather is good.
The energy is
still good.
Still have some juice left in me.
Oh, yeah.
Mondays. That's why
I love these chats. They keep us
invigorated.
Exactly.
This is our show.
We're going to kind of break down, you know, what's the latest, the greatest, what we're excited about in the DSi space.
We both are agents of molecule, as well as a lot of other really cool side endeavors in DSi that have kind of developed pretty well recently.
How are things going with your projects, Kiyo?
Yes.
I think a bunch of, as I said,
like a bunch of launches scheduled.
I don't know, like, when what will happen.
It's still unpredictable.
But, yeah, we are getting there slowly.
And, yeah, we are launching launching uh like from the microband outside
and we are launching bacterias on uh pump.science yeah i i saw that i'm pretty excited about that
too is it all going to be through the pump science interface still yes yes sweet yeah sweet oh man you guys have some good uh like little
micro microbe monsters already so you're you're um like avatar is gonna be sick i can already i
can already tell yeah yeah um are you following the monster reviews that we are doing yeah from
microbound house yes those are poop monsters yeah
yes i love the poop monsters it's too relatable honestly awesome yeah the artist is quite good
like the the guy who yeah yeah so how did how did you go about finding this person they did
you have like auditions or you just knew they were the one yeah like it came
through a referral uh we've been like reaching out a bunch of artists and we collected some samples
and uh this guy turned out to be very good out of those uh so we picked him and uh turned out to be
very good like uh like i think probably next next or week after that, you'll be able to
use the app, use the Poop Monsters app. The Poop AI is going to come out. Yeah.
It's going to be, it's the, it's one of the, you know, project that's so close to my heart. And
I kind of initiated this and I'm still doing the product development for that.
Yeah, I'm super stoked on this product.
You know, this is going to make change.
Like this is going to build that bridge between Web3 and Web2,
specifically for gut health.
It's going to bring a lot of awareness amongst young generation.
So, yeah. lot of awareness uh amongst uh young young generation so yeah yeah it's a i think it's a great transition to bringing things like from chain to the real world so i'm pretty excited
about it too it is it is all right uh let's let's today dig a little more into our experiences within DSi.
Yeah, let's do it.
And I just want to start with you.
If you can give some anecdotal experience on how you perceived DSi when you were out of this ecosystem, right?
Like, I think probably this would be during the interview
where you first came across Molecule and the word Desai
when you got into Molecule.
So what was it back then?
And then how was it when you started and like started learning
about all these, you know, new realities?
And now you are, let's say you are more sort of a seasoned uh a desai maxi i would call it so how is it for
you now right like can you give this three faces of reflection yeah if possible so thinking back um i think my first impression of dsci is you know science
plus crypto um and when and when i was introduced to it in that way i was a pretty skeptical i think
at first because i know nothing about crypto.
And then, you know, and you're like, oh, this is something I don't know.
I'm afraid of it.
It has to do with money, which I don't have any of.
What could it possibly, you know, what could these people that I, you know, kind of not thought highly of contribute to a field that I really like enjoy and, you know,
the field that I'm passionate about. And then I think as I, you know, started at Molecule and got
to know like the D-size space a little bit more, I came to understand, you know, that it's this,
it's this, you know, decentralized solution to a lot of the problems that I had been, you know, felt but maybe didn't have a name for.
And when I was, you know, when I was getting my academic training, you know, the, you know, long timelines for things.
I am so frustrated with the, like, time horizon of academia.
That was the one that probably hit me the most, just that the fact that it, you know, it takes so long to get these things done, it takes so long to do research, you know, there's
got to be a better way. And then, you know, for other people, it's, you know, maybe they're more
aligned with like the funding issues where, you know, only the best or only the research that the
institutions that give out the funding decide get to be funded.
And so, you know, through learning about it with Molecule, I'm like, oh, this is actually
really cool.
And I think it's something that I think is still, I couldn't really understand how early
it was, I think, when I first started.
And then I was happy to be, you know, involved in something at such an early stage.
And then coming through to, you know, fast forward to today, it's been, you know, a thousand years in crypto at this point or, you know, a year and a half.
the I now have a greater appreciation of not just the uh you know the initial things that bring you
into dsci like the funding and the fact that it's decentralized it's not run by this you know any
you know big major institutions or anything like that it's you know science for the people which
I really really like it also is this way of breaking down scientific barriers that I feel like I've also come to know
in academia is, you know, there's not as much collaboration as you'd really like to see. And,
you know, I have seen IndySide, all these different catalysts and, you know, chemical reactions take
place just on the off chance of, you know, the people that you get to meet, the, you know, chemical reactions take place just on the off chance of, you know, the people that you
get to meet, the, you know, the shrinking of the world, you know, we're all digital, we're all on
chain, we, you know, people who are meeting now who have never met before. And that's the inception
of all these brand new ideas, and these new ways of doing things. So, you know, I'd say as a seasoned
D-Sci vet, I'm very hopeful. And I'm excited about, you know, I'd say as a seasoned Desai vet, I'm very hopeful and I'm excited about,
you know, I think that folks handled Desai summer is never going to end. But, you know, the
recent wave, I think people are handling it really well and, you know, capitalizing and building on
what attention has come to the space recently. So long-winded way of saying,
didn't know what the hell I was doing when I jumped in.
Really glad I did.
Colin, I think there's a trouble with your audio.
How long?
I was really going in.
Can you hear me?
Yeah, can you hear me?
Hello?
Hello?
Can you try again
yo yo yo are you here
I might have to
alright let me
invite Carlin again
alright All right. Let me invite Carlin again.
Hello?
Hey, Carlin. Can you hear me?
Yes. Can you hear me me I guess not
I think we lost you
at some point
so until Carlin comes
we have a couple of listeners
here
Rex and Munna
would you guys like to come on stage
if you guys have any questions
for us
happy to answer
yeah feel free to send speaker requests I can bring you up this just like feels like a jam
session so yeah bring any questions that you guys might have in the meantime I can walk you guys through my journey until Carlin comes back.
I can see him, but for some reason, he cannot speak.
Why is it?
All right.
Carlin, do you want to try again
sorry i cannot hear you but can you guys hear me uh i don't know whether the problem is with me
okay awesome all right um yeah so for me when when I started into DSi, of course, I knew very little about crypto or Web3. So I thought, yeah, this is some crowdfunding platform where, you know, people use crypto funds to fund science projects.
to funds to fund science projects.
Then I got into this not knowing much about it.
I spent most of my time, my early time into DSI,
learning about intellectual property,
the basics of blockchain as a technology and all of that.
I really focused on building my fundamentals,
before getting into, you know, the entire DCI ecosystem.
And then eventually, like got more into the science side of the DCI, trying to look at what problems
scientists go through, and how we can improve the systems for the scientific ecosystem altogether
because if you guys are someone not from the scientific ecosystem there's bunch of you know
issues within that for example you might see a professor you might think like professors are usually you
know like taking lectures and doing research at lab but that's not really
the case they are spending most of their time in attending conferences and
writing proposals and grant applications so this is how they spend
most of the time because the bureaucracy is set in a way that you cannot, you know, and that top is the granting agency.
And these granting agencies like NIH, NHS, or any governmental agencies, they set some sort of parameters around to measure the scientific output.
and those parameters are usually seen as the publications so publications are nothing but
And those parameters are usually seen as the publications.
a scientific publication or an article that you write when you complete a research so it's more
sort of an analytical scientific document that you publish to your peers so that you say hey
I found out this so and uh functions within biology and stuff
like that and this is the culprit right earlier it was purely you know curiosity and open science
principles where people did write publications to share their findings so that others can use and build on top of it and they won't waste resources going on
doing it again and again so not pondering on the same things so that was the reason but these days
if you look this has become a mechanism to create that social value or like the social value within the scientific ecosystem so if you
have more publications with higher impact factor journals or like higher citations then you are
seen as a your publication or your science field is seen as something you know more reputable or
like you know you get better chance of funding, getting funded. But this is unfair because imagine things like developmental biology
where someone would still doing research on how a fish embryo develops.
This might not be directly highly influential for human health,
but this does help us in understanding how biology works and this has an extent a
translation potential where learning about fish embryos could at some point help us learn about
how human embryos work or like other frog embryos or like other things work but because of this
the scientists who are doing fundamental research usually get less and less of funding and there is an imbalance
or sort of you know asymmetry in the funding for example instances like you know fields like
women's health or substances which are scheduled drugs like psychedelics or cannabis uh so these sort of things get very less
less funding and uh this is so within the within the ecosystem the pressure kind of trickles down
so the professor gets the pressure from the funding agency uh they say you know you need to publish
three to four papers every every year and uh how the professor would do, basically he has a bunch of postdocs
and junior research assistants
working within the lab.
So they will carry on that pressure further
and then it'll further trickle down
to the postgrads and undergrads
who has to do a bunch of different
job within the lab with the less pay
and you know, like it's like an underpaid overworked situation.
And coming out of this, literally going through all these things that I talked about, gone
through the publication journey, has been that undergrad in the lab.
So went through the whole process of suffering within the
scientific ecosystem it just felt like you know my i've got i've got a solution i felt like this
is the revolution that science needs right and then dsai came in i became super uh you know excited about this entire field and i just focused on
scientists primarily like you know pushing science further and further working for the
scientific ecosystem but eventually as i moved into the decentralized world i came across web3 native movements like deac and bioac and other movements
decentralization movements and that really pushed me into thinking uh decentralization at a large
and that's when i shifted my focus from scientists to citizens who are the end users. So also patient groups, right?
So DISA is not just about helping scientists get the funds.
It is also about connecting the end users
of that scientific commodity.
It can be the knowledge that the scientist creates
or it could be the product or tools and protocols
and databases that they create
and all of this is received and utilized and consumed by someone and that person that consumer
has a very less voice in the scientific process so i thought like decentralization of science could
really benefit that area more.
So I started doubling down on the consumer side.
Yeah, I will stop my monologue and Carlin is back.
Let's check Carlin whether we can hear from him.
Test, test, test. Can you hear me?
I am. You're not hearing me?
No, it doesn't seem to work.
Keeo!
Let me do something.
I have so many things to say.
I'll remove you from co-host
and I'll invite you as a speaker.
Let's see whether that works.
All right. We have Et tate and andrew aquas here uh do you guys want to come up and jam with us uh please i'll bring you guys up i'm back as a speaker anything all right
okay okay awesome let's wait All right.
Okay.
Okay, awesome.
Let's wait.
Hey, Andrew, how are you?
Andrew, I can hear you.
Yeah, Carlin, I can hear you too.
Let's see if Kehoe can hear us.
Kehoe, can you hear us, buddy?
I cannot hear Andrew. I think there is some trouble with the space.
I think it's you, Kehoe.
Definitely some space troubles.
Let me check.
Arlen, lovely to see you again.
Hey, great to see you as well.
What's new, bud?
I should say hear you again.
Yeah, great to hear you.
All right.
So it was me.
It was you. It was you.
It was you.
We're having fun.
You know, this is just kind of what it is.
Can someone speak?
You never.
Yes, we are here to count on four.
are here in account inform.
Kehoe, we love you.
Well, in news,
in news, Carlin,
I'm doing great
at things that are new.
Kehoe!
I'm going down to Edge City,
Edge City, Patagonia,
and doing a little uh citizen science
experiment collaboration with microbiome dow and sideow nice yeah should be really interesting
kind of exploring the gut uh gut microbiome interaction with uh specific dieting but also
with uh traditional plant medicines and finding some
sort of observational data there that we can pose questions to or expand depending on exactly how,
you know, what the data shows. Yeah, that sounds really fun. I love citizen science.
All right, Kehoe's invited me to co-host just a moment here.
All right. Kehoe's invited me to co-host just a moment here.
From a microbiome standpoint, it is shit-ison science.
That's gold.
Can't take credit for that one, but it was tossed around a couple times.
Hey, Kehoe.
Kehoe, what's up, buddy?
I don't know.
I couldn't hear you guys.
But then Andrew texted me saying that you guys can hear each other.
Yeah, we were having our in-tantem combo.
Awesome.
Awesome.
I'm back with Mari.
For his little account.
And for anybody that listened earlier and heard us both the whole time, if you're listening to this afterward, we knew exactly what we were doing.
Awesome.
All right.
Guys, go ahead.
Hi, Andrew.
How are you doing? Just telling Karlyn a little bit about the initiative over at Edge City, what we're planning
next month in about 30, what is it, 33, 32, 33 days?
Wow.
Yeah, I think this is a one-off study, and I'm super pumped about this.
There's a lot to explore in this domain specifically you know
how these microbiomes metabolize any drugs in that sense yeah and especially for psychedelics
which has a very
difficult topic with its science. People still try to struggle with contemplating what is
consciousness and what is mind. So I think this is going to dig deep into a bunch of different scientific fields, but I'm super excited for the microbiome and the psychedelic aspect of it.
You hit the nail on the head there.
I mean, we're collaborating with the Consciousness Residency over at Edge City, which for those who are not familiar, Edge City is a pop-up village taking place for a month.
Happens every three, six months in different places in the world, typically organized around some sort of event.
So at the end of this month-long pop-up will be DevConnect in Buenos Aires, Argentina, a big Ethereum conference.
And so the residencies,
which are groups of like five to 50 people
that are organized around a similar topic,
specifically the consciousness residency
is the one we're collaborating with here
because the microbiome has shown
that the things that affect consciousness,
things that are conscious
and things that are consciousness
can be in the smallest level,
the microscopic level.
And for those who are familiar with psychedelics themselves or accounts of psychedelic experience, there's this macroscopic
idea that consciousness is larger than us as well. So we're kind of bridging those things with what's
right in the middle, which is us human beings and us human beings, and seeing what sort of data we can, we can pull out of it. Very excited.
Consciousness is larger than all of us.
Like the collect, like all of our consciousness plus some,
that's kind of crazy.
I'm, I'm so new to that space. I'm,
I want you guys to share some stuff with me about your findings.
Cause.
Yeah.
Essentially to give you some background on kind of what this study comes from is just like some preliminary studies that have shown that the composition of your microbiome, so specific microbiota,
they can modulate the onset or intensity or and intensity of the psychedelic experience.
So, for instance, the active psychoactive component from a mushroom is psilocybin,
but psilocybin breaks down into psilocybin, which is actually the thing that affects your cognition.
it, which is actually the thing that affects your cognition.
And the microbiome aids in that molecular breakdown from psilocybin to psilocin, so
it can have some sort of impact on that experience.
Makes sense.
So yeah, should be exciting.
Should be exciting.
Yeah, that's great.
Is this your first citizen science experience that you're going to have?
Yeah.
You're not new to this. You're true to this.
I'm true to this. Well, so I've done like some citizen science stuff that was not necessarily
decentralized science stuff. So there's a project in New York city. That's really cool. It's called
a billion billion oyster project to restore oysters, uh, to their native habitat in the
Hudson and East rivers. And it's a big citizen science initiative gets educational, um, institutions
involved, you know, kids getting involved in that's really, really cool. Um, but yeah, I mean,
this is going to be the big one that i'm
facilitating myself going down and really being boots on the ground for so pumped yes love it
we need more of our uh our edu apostles uh heading out there absolutely 100 yeah i think for me the primary interest for this study came out of my own psychedelic
experiences yeah like because like I have had these psychedelic experiences several times
and it differs based on the location most of the times I try to do it in nature and I'll prepare myself sort of, you know,
with a very good diet and fast a little bit before the psychedelic experience or taking any psychedelics.
So this journey stemmed out of that.
And now like deep into the gut microbiome space understanding what gut
microbiome is there's definitely you know a connection there where you could then just
optimize your microbiome to optimize your psychedelic experience you know or or you know
you can optimize the dosage right like you don't have to take so and so level of dosage
for you probably this might be very subjective to each of us and the experiences are also subjective
so i think this will help really in optimizing that dosage not not just to cyclic, but to any drug compound that we are
taking. In future, I guess there will be a gut pharmacodynamic or pharmacokinetic module within
any sort of clinical trials for any drugs that's getting launched, which will look into the
compatibility and all sort of the ADME aspect of drug in response to gut microbiome.
So then in future, we might have dose optimization by just looking into the gut microbiome.
So you might not have take, you know, 450 mg or like 250 mg.
You can even take less depending on how efficient your microbiome is or you can even take
a pill that creates that efficiency before you take the drug something something yeah i like that
too the pre-prep exactly a pre-prep and post-prep they should have a gut barmico kinetic thing
already it feels it feels like a major missed opportunity so I'm glad you're feeling
that need Keoh. Exactly yeah definitely gut microbiome centered pharmacokinetics is
something that I guess like there are a couple of pharma companies already within this gut
microbiome domain started this not not let us scale but they are building the the the
you know the basic foundation for yeah you were talking about foundational work earlier that it
needs to be done exactly yeah i'm a foundational scientist myself so i uh i hold development near
and dear to my heart exactly so let's let's hope i think this is the future man like uh you can
kind of tie uh anything and everything to your gut microbiome because it sits in a very uh
important spot right like be it diet or be it drug anything that you consume eventually ends
up in your gut the first place it ends up is your gut and uh and it gets touched by these bacterias
instantaneously and they kind of aid in all sort of metabolism absorption and stuff like that
imagine so i've been like looking at a bunch of folks that microbiome now made and i saw
a post about metformin modulates gut microbiome, something like that.
I was, I was, you know, I wanted to ask the question, what if I don't have that bacteria, which metabolizes metformin?
Or what if I don't have that compatibility because my gut microbiome doesn't really respond to metformin?
And what would happen right like so i think the key lies there
what we need right now is a a sophisticated data layer a bunch of data that informs us of how
microbiomes look across populations you know because right now if you see
You know, because right now, if you see the entire microbiome information comes out of primarily the Western population.
So if you would build any model based on this, this model might not work for the global population.
Right. I think there was a recent paper that looked into people from Honduras, a village in Honduras.
They found like 150 new species in that population, which was never found before.
So imagine if you would start mining all human, you know, like if you start mining different ethnic groups within like across the globe,
mining different ethnic groups within within like across the globe uh what sort of bacteria we might
find out what sort of uh you know genetic capabilities these microbes would have yeah
because right now we are running at a loss we are running with half our capacity we already lost
almost 44 percent of our ancestral microbes if you compare yourself with the Tanzanian tribes, there is a 44% loss.
So it's, we are running with half its capacity. I think this could be the reason for the surge in
metabolic disorders and mental health issues, because the superhighway is there, right? Like
gut and brain is super connected uh it works both ways
and you have like highest amount of nerve endings next to the brain attached to the gut so yeah
what can i say like the science just like clearly tells us this is something quite crucial and
and sort of a centerpiece for all other diseases.
What we are lacking is basically the data
to make the next steps.
It's also really interesting as we're talking about this
because I think of like folks talking about their best psychedelic,
like, you know, a lot of people's common psychedelics experiences,
the best ones they say are, you know, related to like nature. So I'm like, is there a difference
between, you know, taking even like a, you know, an over the counter drug in the wilderness,
like in nature in the wilderness versus in the city or something? Do you have any insight into
like how, I guess, i guess maybe this has already been
done but like the you know urban versus more like a rural life how does that affect your like
microbiome do you know uh from just anecdotal experience i think um doing it in nature does have an effect probably you are like it depends on like how
how connected you are are you going out in nature and sitting at a like you know a bench and not
interacting with the nature then it's different but if you're like really interacting with it i
used to go for picking strawberries and you know like picking flowers and stuff like that so i really interact with nature then
probably you are taking up bacterias from that ecosystem from the soil from the nature so it
might have an effect like usually i suggest my friends to at least spend one hour in nature
every week this kind of helps you boost your gut microbiome diversity. That's quite important.
It's not just about promoting the good ones to a larger extent
because that's not diversity.
We need to build an ecosystem.
If you're just growing roses, you know, then it doesn't work.
You need to have a diversity of flowers, diversity of animals.
So you need diversity of microbes within your gut yeah
yeah there's maybe something to like the you know you're around a lot of people but not necessarily
like the differing organisms in in like a more city city-based uh environment so there maybe
you know the homogeny of it all is also not great for you as far as like building your
your biome uh portfolio exactly a biome portfolio yeah it's quite important uh but i know i don't
know like for this experiment like for this citizen science study we could also like try this as one
of the variables uh i don't know where exactly the
location is uh andrew do you think is the space uh surrounded with nature or is it in the within
the urban limits this will be in yeah it's very nature immersive um it's specifically the edge
city is in san martin de los andes and it's basically this town that is on a lake and there's mountains
that are on all sides of the lake except for where the town is it's it's um beautiful looking it up
but it's very nature immersive there's going to be like nature walks every morning and a lot of
people that are active uh and activities to to get people out and about.
Because that's where you formulate the most innovative collaborations.
When you're out in that type of setting, it can really inspire.
I get my best ideas walking.
Yeah, there you go.
I can't sit if I'm on the phone.
No, facts. I totally agree. I'm pacing the phone. Yeah. No, facts.
I totally agree.
I'm pacing as we speak.
Yeah, I think that sounds,
it sounds like it might be a great positive data point
to add to our nature hypothesis then.
So that'll be good.
So that'll be good.
So add to what Kehoe was saying as well.
It's food for thought, right?
It's just food for thought.
But there's a lot of, I don't know how much everybody here has been exposed to it, but one of the first forms of decentralized science itself was during the, you had websites like AeroWid,
where people who were experimenting with these substances
would provide really detailed accounts
of their subjective experiences,
as well as quantitative data like their jokes.
And they would put them on this forum called Erewhid. And, you know,
through Erewhid, if you've ever interacted with it, there's this, you know, common thread of ideas
with certain things. You know, it expands consciousness to that which, you know, on a
normal day to day, you're not quite as in tune with. So if you think about it that way,
and you look at consciousness as something
that every living thing experiences, maybe living in,
but let's just say living thing experiences
to a certain extent, then if you're out in nature
and expanding your own consciousness
in accordance with all of these other living things,
then maybe, just maybe, that is a reason that people feel this oceanic experience or this other,
this oneness, right, when they're in nature,
as opposed to like a city setting or urban setting
where there's a little bit less of that or less concentrated form of that.
And maybe that has to do with the microbiome,
the microverse that you are in, you know,
in interacting with food for thought,
but maybe this data set will help us show just that.
Love it. Love it. I'm into the idea.
I think that non-living things have consciousness too. I could be, I could get down with that. Prove me wrong, you know?
how decentralized we can go with the intellectual property that would come out of this research
so there is a an option for for participants to become co-owners of the study
so that is something that we are trying which has what which has been kind of What is involved in that, do you think?
Sorry?
If you're a participant, but you're also, you know,
have ownership of the study,
what do you think that looks like?
I think it would bring a lot of responsibility to the participants
if we kind of create that skin in the game for them.
So they'll be more responsible in terms of reporting their experiences
to close to truth or subjective truth rather than just doing the sort of, you know, play, gaming the system just by just using this to farm
ownership or farm tokens and stuff like that. So when you put participants and give them this
skin in the game by making them co-owners, so they'll have not the prefer, but rather the responsibility to report honestly and of their experiences and record all those things so that then all this could translate to a higher value of the IP that they are co-owning.
So I think this is an interesting model that will be tested here.
Let's see how it goes.
And I was also proposing to make buy-in offers to participants
so that if they buy-in and then if they successfully complete the study,
they can get a yield over the buy-ins.
Oh, nice. Yeah. yield over the buy-in. Oh, nice.
Yeah.
I like the sound of that.
That's a pretty straightforward path
to the incentive that you kind of lead up with in the front.
So I think that that's a pretty solid plan.
Makes sense to me.
It is, right?
I would buy into it.
It is, right?
Yeah. So if you are a participant um you are naturally a co-owner because you are contributing your data
to build this ip so the data room is the ip so it's basically your data that's becoming the ip
so you need to be a co-owner and i think that's all with the ethos of citizen science,
primarily, you know, putting citizens first.
And if this succeeds and if this model really scales up,
this has been one of the biggest vision that MicroBramDAO had from the beginning.
And then we were, like like just lucky enough to find
scidao which also has the same principles and have been working this even before us
you know like promoting citizen science trials and building infrastructures and tools for that
so i think it's a good good match right from the beginning yeah
good match right from the beginning. The idea is if this scales up, this will create a rift within
the scientific ecosystem because as I say always, science still now, till now, it's constrained to
the institutional boundaries. So if you need to do science, you need to do it within an institution
because of infrastructure, because of regulations and stuff like that. Yeah. But these citizen
science movements will create that drift where science will not be within institutional boundaries.
Rather, it is happening where the citizens are, where the people are, you know, and it cannot work, it will not work for all scientific domains, but there are certain aspects of research, whichever is touching users at a personal level can adopt these citizen science models to drive better products, better goods, or better models of
ownership and equitable access to all its consumers. Yeah, absolutely.
It's, you know, it's, I think you're right when you talk about a potential rift, but I think it's
not a bad rift because it's, at this point, you know,
the parts of science that if they didn't necessarily fit into the paradigm that already
existed with the, you know, set up by these institutions, they just were like, you're
not real science, go away.
And now it's like, oh, there's a chance for things that, you know, both things that already
existed in this space and things that, you know, are things that already existed in this space and things that, you know,
are brand new, which I am really excited about to, you know, build on each other and get the
chance to, you know, play off the old ways, build into the new ways. I don't know if you heard, but
Raptor, one of the pump science tokens, is looking to go coin to company. So that's like a new
avenue that we're trying to build from
on-chain to off-chain, maybe back on-chain, maybe stay off-chain, whatever sort of the people
decide. And I think that letting the people decide is the point where these things all kind of
coalesce. And that's, to me, the best way forward because, you know, people may not necessarily always know what's in their own best interest, but I think they do more times than we would give them credit for.
And so I'm just really, again, excited about what Microbiome Dau is doing, all the pump science stuff, the side-out things.
I got to get some of these legal derivatives to, I've never really engaged with
like psychedelics too often, just like really one off or two off casual usage, but definitely
I'm interested in, you know, trying out some more stuff and getting engaged in this higher
consciousness with everybody.
Andrew love having you on man
I've missed you I've missed all our
EDU people I see a Ted in the
audience as well
I think we should do a get together
EDU get together
you should bring them to the EDU I think we should do a get-together, DCI-EDU get-together.
You should.
I want to check in. Bring them to DCI offices.
Yeah.
Next couple weeks.
Maybe not next week.
I think Kehoe is going to be traveling.
What you got coming up next week, Kehoe?
I'm traveling to network school,
Singapore,
or let's say Malaysia,
Singapore,
especially in an economic zone.
And we are teaching DSI EDU Fall Edition there.
It'll be running for a week.
We have five modules and a Builders Day.
So it's going to be a very different experience.
We have 300 residents at network school this month
a lot of signups uh hoping to meet a bunch of folks there uh the next set of uh dsai
enthusiasts oh yeah yeah let's try to love it yeah love it man i wish I could go with you I've never been to Singapore or Malaysia
soon like once you once you get done with your PhD yeah we can make that
happen cool I'm gonna hold you to it soon very soon I'm probably gonna be
finished in the next few months so we're really coming up on it
and then
you will be called Dr. Carlin
that's right I'm going to put it in my name and everybody's
going to have to address me as such
until further notice
okay
great so
if you would run a show I would
name it Dr. Carlin and Kehoe so that I can
also share the doctor.
Absolutely.
You can have my last name too, Keeho.
We can both be Dr. Compton.
Awesome.
Great.
Yeah.
Anyone want to ask questions or jam with us, feel free to, you know.
ask questions or jam with us uh feel free to you know
probably if you guys are requesting any speakers just scrape your hands i'll
i'll let you guys come up on stage and uh yeah it's it we have it from
uh dcadu we have ed we have cyrus a bunch of new DCADU. We have Ed.
We have Cyrus.
A bunch of new friends.
Hello, new friends.
Some builders.
Love to see it.
We got Mana in here.
What up, Mana?
Mana is our regular. Mana is our regular.
What's up, buddy?
Jim, Jim, guys.
Hi, Colin.
Hi, Q.
Q's nice to listen to you guys.
So sorry.
I'm kind of caught up in work right now,
so I was just listening.
But interesting conversations.
It's been a while.
I joined the office space,
the office hours rather.
So it's really, really interesting.
I mean, I was busy jotting down some things on the side also.
Thank you guys for having me.
Nice.
Love to hear it.
What are you working on today?
If you don't mind me asking.
Yeah.
Currently, we are planning uh organizing the nigerian
blockchain week uh so i'm kind of like working on three different sites simultaneously uh wow
so it's kind of crazy right now sweet when is the when is nigerian blockchain week uh it's gonna
come up in septa two weeks from now on i I think. September 22nd.
No, that's actually less than a week from now.
Oh, my goodness.
Godspeed.
Yeah.
Thanks a lot, guys.
You got this, man.
It's going to go great.
Any Desai things that you're particularly excited about?
Right now, to be honest,
I had some more like personal stuff stuff i have a daughter now so
congratulations yeah girl dad i love it thank you uh i've been a distracted it's been i've
been distracted for a while so i kind of like want to fix all these sites, hopefully before the end of today, tomorrow,
so everything runs smoothly.
They'll just have to deal if not,
because you got to take care of that baby.
Love it.
We got Red Energy.
What's up red energy
hey um can you hear me yeah how's it going uh it's good okay how are you good good
so i'm a newbie forgive me if i have if i ask any wrong questions but uh I really want to understand, you know,
DSI tokenization. I have no idea.
Would you be willing to share for a beginner like me?
Yeah, absolutely.
Keeho, maybe you got a tokenization simple breakdown for us yeah we can we can do that awesome all right
i was also met with someone at dsai india who had the same same question cool yeah the question
was something similar to this they they didn't have like a fundamental
understanding of tokenization uh also like it was a little confused with other products
other crypto narratives yeah but let's use token exactly yeah just just to break it out uh how it
works in the the dsai the the scientific ecosystem is so all scientific emulations are
something related to knowledge so knowledge is the commodity so when you create a knowledge let's say
i'm a researcher and i'm creating a drug for hair loss and you are someone affected by hair loss
and you want to find hair loss research because hair loss is painful you are someone affected by hair loss and you want to fund hair loss research because hair loss is
painful you are suffering right so your options available for you are either to go to a pharma
to you know let them invent a new shampoo for you which helps with hair loss or you can go to
institutions run by governments and say hey i having i'm having this hair loss or you can go to institutions run by governments and say, hey, I'm having
this hair loss problem. Can you solve this problem for me? Right. But the problem is
hair loss is not a big problem for neither the farmer nor the institutions. So they're
not going to come and invent that, solve that problem for us. So what we can do with this
case is you and other friends like me who
has the same hair loss problem can join together put like one dollar each and then now we have like
thousand dollars we can go find a researcher and give them this money to hey invent me a solution
that solves my hair loss problem let's say the scientist comes with a shampoo which solves this problem, right?
Then we all contributed a certain amount of money to this. So proportional to that money that you
contributed, you will receive something called tokens, which is a fractionalized ownership over
that shampoo. So if the shampoo makes $1,000 profit, then you will get your fractional amount of revenue out of it but
this real world asset revenue model is still in cooking with Molecule V2 model but as if now
the model lets you have governance rights which are something like a power to control that product. Do you want to commercialize this shampoo
or do you want to sell the shampoo to a certain company to white label it?
All these decisions can be done by you as a token holder.
So that's basically fractionalizing the intellectual property
or the knowledge, which is shampoo.
Thank you. Well explained. I think I missed one part where how am I contributing in this
you know hate loss treatment in the in the example that you provided
where is my contribution I think I missed that part. Yeah you can contribute different ways.
You can contribute by funding the experiment which is like your dollar that you contributed for the
product development or you can help us test the shampoo as a patient yourself or a user yourself you can test the shampoo and help
develop the product because you also own part of that shampoo's profit so you have more skin in the
game to develop the product to be better so you can play different roles in here if you are a
patient if that's the driving force for you to commit to this project to fund this project then you can try it for
yourself or use the product for yourself or if you are just interested in you know funding this
research so that for example like alzheimer's disease probably you are 20s now but there is
a possibility of alzheimer's onset and let's say 30 40 years down the line so you can invest on
something focusing on alzheimer's disease now you don't need to be a. So you can invest on something focusing on Alzheimer's disease now.
You don't need to be a real patient. You can just be interested in solving that problem so that
when you go there, there is already a cure for that.
Well said.
Noted. So someone like me probably won't be doing any intellectual contribution or, you know, the patient testing contribution.
Like, people can, you are saying, invest money.
So, do people get, where can people get an understanding of, and can people pick and choose on what kind of molecule or in an investigation research
that is happening? Two questions. Can people pick and choose on what research they want
to invest? Second thing is, do we get to see the entire list of you know the ongoing activities and yeah yes so getting an entire grasp of what's
happening in dsci is little difficult because there are a bunch of different things but you
can look at majority of the project that listed within the Molecule ecosystem being one of the forerunners of this.
So if you go to Molecule.xyz, you will see a bunch of these IP tokens or projects that are
funding different aspects of science. It's not just related to human health, also climate.
not just related to human health also climate um hair loss was one example there is actually a hair
dow which has a token and they did really invent a shampoo uh through the citizen science model
so it's not just about hair loss there is women's health uh there is microbiome health there's
mental health there are psychedelics research a bunch of different
communities so you need to pick and choose what really resonates with you or like what is something
that is close to you that you would you know contribute to it not just with funding but also
like play an active role in being this community member and then once you become part of the DAO
you will have more voice in choosing which projects the DAO will fund. You know, once you become a DAO member, you
will vote on every decisions that the DAO makes. So probably you can bring new projects
that you think could be valuable and then pitch it to the DAO. And if the project seems
legit and seems to be worth investing, then the crowd will vote in a democratic way and then
yeah it'll it could be funded and yeah that's i hope that answers your question so for list of projects you can go to molecule xyz molecule.xyz for finding these projects that are close to your
heart or like close to the field that you want to invest in, you need to dig deeper and find which organizations are working on that.
So I think there are a bunch of DAOs working on this different areas.
Thank you, Diego.
All right.
Thank you, Red Energy, for some great questions,
especially for people who are just getting into the space.
We welcome all levels of questions here Thank you, Red Energy, for some great questions, especially for people who are just getting into the space.
We welcome all levels of questions here and happy that we were able to sort of break down the IPT framework for you.
I think that brings us to the top of the hour.
It is. It was a wonderful call uh yeah i think who is uh tuning into this call first few minutes i say first 10
minutes was actually 10 minutes i promise it gets better awesome let's i'll tune in back and listen
to it i need to jump uh but yeah it was nice meeting you guys. Thank you guys for your time and tuning in and your questions and jamming with us.
Stay tuned.
We are coming back again next week in DeSai Officers.
Yep.
All right.
Thank you so much.
Keep building.
Keep growing.
We love you.
See you later, DeSai.
Bye-bye.
Bye.
Have a good one. Bye. Thank you.
